<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        43-490-09
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CEFPROZ 250MG-5ML POWDR FOR ORAL SUSP
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CEFPROZIL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Powder for oral suspension
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        50
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        32.25
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="MEDPHARMA PHARMACEUTICAL &amp; CHEMICAL INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            MEDPHARMA PHARMACEUTICAL & CHEMICAL INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01DC10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cefproz suspension is indicated for the treatment of patients with the<br />following infections caused by susceptible strains of bacteria.<br />Adults and children over 12 years old:<br />- Upper respiratory tract infections, inflammation of the pharynx,<br />tonsils, and nasal sinuses.<br />- Lower respiratory tract infections, acute and chronic bronchitis and<br />inflammation of the lungs.<br />- Skin infections.<br />- Uncomplicated urinary tract infections including acute bladder<br />inflammation.<br />Children from 6 months to 12 years old:<br />- Upper respiratory tract infections, inflammation of the pharynx,<br />tonsils, sinuses and middle ear.<br />- Uncomplicated skin infection.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Cefproz Suspension is contraindicated in patients with known allergy<br />to the cephalosporin class of antibiotics or to any component of the<br />cefprozil preparations.<br />Warnings<br />Before therapy with Cefproz Suspension is instituted, careful inquiry<br />should be made to determine whether the patient has had previous<br />hypersensitivity reactions to Cefproz Suspension, cephalosporins,<br />penicillins, or other drugs. If the product is given to penicillinsensitive<br />patients, caution should be exercised because crosssensitivity<br />among beta-lactam antibiotics has been clearly<br />documented and may occur in up to 10% of patients with a history of<br />penicillin allergy. If an allergic reaction to Cefproz occurs,<br />discontinue the drug. Serious acute hypersensitivity reactions may<br />require emergency treatment measures.<br />Pseudomembranous colitis has been reported with all antibacterial<br />agents including Cefprozil, and may range from mild to lifethreatening.<br />Therefore, it is important to consider this diagnosis in<br />patients who presented with diarrhea subsequent to the administration<br />of antibacterial agents. After the diagnosis of colitis has been<br />established, therapeutic measures should be initiated.</p><p>Take special care with Cefproz Suspension<br />&bull; Aspartame is a source of phenylalanine. It may be harmful if you<br />have phenylketonuria (PKU), a rare genetic disorder in which<br />phenylalanine builds up because the body cannot remove it<br />properly.<br />&bull; this product contain sucrose If you have been told by your doctor<br />that you have an intolerance to some sugars, contact your doctor<br />before taking this medicinal product.</p><p>General<br />The total daily dose of Cefproz Suspension should be reduced in<br />patients with severe renal impairment (creatinine clearance<br />&le;30ml/min) because high and /or prolonged plasma antibiotic<br />concentrations can occur from usual doses. Cephalosporins,<br />including Cefproz Suspension should be given with caution to<br />patients receiving concurrent treatment with potent diuretics since<br />these agents are suspected of adversely affecting renal function.<br />Prolonged use of Cefproz Suspension may result in the overgrowth of<br />nonsusceptible organisms. If superinfection occurs during therapy,<br />appropriate measures should be taken.<br />Positive direct combs tests have been reported during treatment with<br />cephalosporin antibiotics.<br />Drug/Laboratory Test Interactions:<br />Cephalosporin antibiotics may produce a false positive reaction for<br />glucose in the urine with copper reduction tests (Benedict&rsquo;s or<br />Fehling&rsquo;s solution Clinitest&reg; tablets﴿,) but not with enzyme-based<br />tests for glucosuria ﴾eg, Clinistix&reg;﴿. A false negative reaction may<br />occur in the ferricyanide test for blood glucose. The presence of<br />Cefprozil in the blood does not interfere with the assay of the plasma<br />or urine creatinine by the alkaline picrate method.<br />Carcinogenesis, Mutagenesis and Impairment of fertility:<br />No mutagenic potential of Cefprozil was found in appropriate<br />prokaryotic or eukaryotic cells in vitro or in vivo. No in vivo longterm<br />studies have been performed to evaluate carcinogenic potential.<br />Reproductive studies revealed no impairment of fertility in animals.<br />Other medicines and Cefproz&nbsp;</p><p>Please tell your doctor or pharmacist if you are using or have recently<br />used any other medicines. This includes medicines that can be bought<br />without a prescription and herbal medicines.<br />&bull; Cefproz should not be combined with aminoglycoside antibiotics<br />(e.g. streptomycin or gentamicin) could cause kidney damage.<br />&bull; Strong diuretic medications (e.g. furosemide) could be coadministered<br />with Cefproz damage kidney function.</p><p>Concurrent administration of probenecid slows the excretion and<br />enhances the effect of Cefproz.</p><p>Pregnancy and lactation<br />If you are pregnant or breast-feeding, do you think you may be<br />pregnant or planning to become pregnant,<br />talk to your doctor or pharmacist before taking this medicine.<br />During pregnancy and lactation, Cefproz should not be used. Unless<br />the need has been clearly established.<br />Caution be exercise when administering Cefprozil to nursing women.<br />Pediatric Use:<br />Safety and effectiveness in children below 6months have not been<br />established.<br />Effects on ability to drive and use machines:<br />Cefproz Suspension is not known to affect your ability to drive and<br />use machines. Make sure you know how you react to your medicine<br />before you drive, use machines, or engage in any other activity that<br />could be dangerous if you are not alert.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Cefproz Suspension exactly as your doctor has told you<br />to. Check with your doctor or pharmacist if you&rsquo;re not sure.<br />Cefproz Suspension to be administrated without regard of meals,<br />since food has no significant effect on absorption.<br />Adults and children over 12 years:<br />Cefproz Suspension is administrated orally in the treatment of<br />infections due to susceptible bacteria in the following doses:</p><p>upper respiratory infections:<br />Pharyngitis/Tonsillitis<br />500mg every 24 hours<br />Sinusitis 250 to 500 mg every 12 hours<br />Lower respiratory infections 500mg every 12 hours<br />Uncomplicated urinary tract<br />infections<br />500mg every 24 hours<br />Skin &amp; skin structure<br />infections<br />250mg every 12 hours or<br />500mg every 24 hours<br />Or 500mg every 12 hours<br />Children less than 12 years:<br />In clinical trials, Cefproz suspension has been administrated to<br />children who were at least 6 month old.<br />In otitis media, the recommended dose of Cefproz suspension is 15<br />mg/kg administrated every 12 hours.<br />in upper respiratory tract Pharyngitis/Tonsillitis and acute sinusitis 15<br />mg /kg/day divided into two equal doses. For moderate to severe<br />acute sinusitis infections, the higher dose should be used. the dose is<br />15 mg/kg every 12 hours.<br />In Uncomplicated skin and skin structure infections, 20 mg/kg once<br />daily is recommended.<br />The maximum pediatric daily dose should not exceed the maximum<br />daily dose recommended for adults. In the treatment of &beta;- hemolytic<br />streptococcal infections, a therapeutic dosage of Cefproz suspension<br />should be administrated for 10 days.</p><p>Renal impairment:<br />Cefprozil may be administered to patients with impaired renal<br />function. No dosage adjustments is necessary for those patients with<br />creatinine clearance values&gt;30ml/min. For those with creatinine<br />clearance &le;30ml/min, following administration of the first standard<br />dose, 50% of the standard dose subsequently should be given at the<br />standard interval. Cefprozil is in part removed by hemodialysis;<br />therefore, cefprozil should be administered after the completion of<br />hemodialysis.<br />Hepatic impairment:<br />No dosage adjustment is necessary for patients with impaired hepatic<br />function.<br />Directions for preparation:<br />1. Remove cap from bottle by pressing down and unscrewing.<br />2. Remove the desiccant capsule which is placed on the top of the<br />bottle and discard.<br />3. Add sufficient quantity of water up to the bottle mark.<br />4. Replace the cap and shake well after addition of water until a<br />homogeneous suspension is obtained, check the<br />volume and if required add water up to the bottle mark and shake<br />well.<br />If you&nbsp;take more Cefproz than you should</p><p>If you take more medicine than prescribed or if the product is<br />accidentally ingested by a child<br />seek medical advice immediately.<br />If you forget to take Cefproz<br />If you forgot to take a dose at a specified time, you can take an entire<br />twelve hour or whole take the 24-hour dose at the latest with a delay<br />of 6 hours. With longer delays, you have to simply skip the twelvehour<br />dose, do not increase the next dose.<br />At twenty-four hour intervals between doses, you can place a full 12-<br />hour delay take half the dose and then<br />proceed normally at a normal time. You skip the whole take 24<br />hours, continue with the next dosing<br />normally, at a specified time non-increased fixed doses.<br />If you stop taking Cefproz<br />Please inform your doctor about this</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Cefproz Suspension can cause side effects, but<br />not everyone gets them.<br />all reported adverse events by organ class and frequency (&ge;1 / 10),<br />common (&ge;1 / 100 to &lt;1/10), uncommon (&ge;1 / 1,000 to &lt;1/100), rare<br />(&ge;1 / 10,000 to &lt;1 / 1,000), very rare (&lt;1 / 10,000) available data<br />cannot be determined). Within each frequency grouping, undesirable<br />effects are presented in order of decreasing seriousness.</p><p>Cefproz is usually well tolerated, but the following side effects<br />may occur commonly:<br />Diarrhea, nausea, vomiting, abdominal pain, dizziness, itching,<br />itching and inflammation can often occur in the genital organs.<br />uncommon, skin redness, rash (skin symptoms usually disappears a<br />few days after the treatment is completed), restlessness, nervousness,<br />insomnia or sleepiness, head pain, confusion. Also, these changes are<br />transient.<br />Rarely, jaundice, increased bilirubin in the blood, decreased kidney<br />function.</p><p>Very rarely, changes in liver function tests, changes in blood count<br />and inflammation of the gut called pseudomembranous colitis.<br />If any side effects, especially diarrhea or other unusual reactions<br />occur, contact your treating physician who decides to proceed<br />To report any side effects please contact:<br />National Pharmacovigilance Center (NPC)<br />Fax: +966-11-205 7662<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Store below 30&deg;C prior to reconstitution. Once reconstituted, store<br />in refrigerator between 2&deg;C to 8&deg;C and use within 14 days.<br />- Shake well before use.<br />- Keep out of reach of children.<br />- Do not use after the expiry date stated on the label.<br />- Do not use if there is any physical change on the product.<br />- Medicines should not be disposed of via wastewater or household<br />waste. Ask your pharmacist how to dispose of medicines no longer<br />required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Each 5ml of reconstituted suspension contains:<br />Active substance is: Cefprozil 125mg or 250mg as Cefprozil<br />monohydrate.<br />Inactive Ingredients: Aspartame, Colloidal silicon dioxide, Citric<br />acid anhydrous, Sodium benzoate, Glycine, Xanthan gum, Disodium<br />edetate, Sodium citrate, FD&amp;C Red No. 40 lake, Sucrose, Tutti fruity<br />flavor and Banana flavor.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Cefproz Suspension 125mg/5ml: Dry powder is light pink powder
with pleasant tutti fruity odour. Powder for 50ml of dry Suspension is
filled in Type III amber glass bottle with desiccant capsule placed on
the bottle and sealed with childproof cap, placed inside a box along
with plastic dosing cup and a leaflet. Reconstituted suspension is pink coloured moderately viscous,
homogeneous suspension free from foreign particles with sweet,
pleasant fruity taste.
Cefproz Suspension 250mg/5ml: Dry powder is light pink powder
with pleasant tutti fruity odour. Powder for 50ml and 100ml of dry
Suspension is filled in Type III amber glass bottle with desiccant
capsule placed on the bottle and sealed with childproof cap, placed
inside a box along with plastic dosing cup and a leaflet.
Reconstituted suspension is pink coloured moderately viscous,
homogeneous suspension free from foreign particles with sweet,
pleasant fruity taste.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Medpharma Pharma. &amp; Chem. Ind&rsquo;S (L.L.C.)<br />P.O.Box:25235, Industrial Area No: 13, Street No: 37, Sharjah,<br />U.A.E.<br />Tel: +971 6 514 8801<br />Fax: +9716 544 0500<br />E-mail: infomedpharma@valeant.com<br />For any information about this medicinal product, please contact<br />the local representative of the Marketing Authorization Holder:<br />ZIMMO TRADING CO.LTD.<br />8, Al-Washm St., Al-Murabba Square, Riyadh, KSA.<br />Tel: +9661 4021068<br />Fax: +9661 4021986<br />E-mail: info@zimmo.net</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                12/2017
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>NA</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            NA
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cefproz 250mg/5ml
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 5ml contains: Cefprozil 250 mg as Cefprozil Monohydrate
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Powder for Oral Suspension
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefproz are indicated for the treatment of patients with mild to moderate infections caused by<br />susceptible strains of the designated microorganisms in the conditions listed below:<br />Upper Respiratory Tract:<br />Pharyngitis/Tonsillitis:<br />Caused by Streptococcus pyogenes.<br />NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections,<br />including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route.<br />Cefprozil is generally effective in the eradication of Streptococcus pyogenes from the<br />nasopharynx; however, substantial data establishing the efficacy of cefprozil in the subsequent<br />prevention of rheumatic fever are not available at present.</p><p>Otitis Media:<br />Caused by Streptococcus pneumoniae, Haemophilus influenzae (including &szlig;lactamaseproducing<br />strains), and Moraxella (Branhamella) catarrhalis (including &szlig;-lactamaseproducing<br />strains).<br />NOTE: In the treatment of otitis media due to &szlig;-lactamase producing organisms, cefprozil had<br />bacteriologic eradication rates somewhat lower than those observed with a product containing a<br />specific &szlig;-lactamase inhibitor. In considering the use of cefprozil, lower overall eradication<br />rates should be balanced against the susceptibility patterns of the common microbes in a given&nbsp;geographic area and the increased potential for toxicity with products containing &szlig;-lactamase<br />inhibitors.<br />Acute Sinusitis:<br />Caused by Streptococcus pneumoniae, Haemophilus influenzae (including &szlig;-lactamase<br />producing strains), and Moraxella (Branhamella) catarrhalis (including &szlig;-lactamase-producing<br />strains).<br />Lower Respiratory Tract:<br />Secondary Bacterial Infection of Acute Bronchitis and Acute Bacterial Exacerbation of<br />Chronic Bronchitis:<br />Caused by Streptococcus pneumoniae, Haemophilus influenzae (including &szlig;-lactamase -<br />producing strains), and Moraxella (Branhamella) catarrhalis (including &szlig;-lactamase-producing<br />strains).</p><p>Skin and Skin Structure:<br />Uncomplicated Skin and Skin-Structure Infections:<br />Caused by Staphylococcus aureus (including penicillinase producing strains) and Streptococcus<br />pyogenes. Abscesses usually require surgical drainage.<br />To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefprozil<br />and other antibacterial drugs, cefprozil should be used only to treat or prevent infections that are<br />proven or strongly suspected to be caused by susceptible bacteria. When culture and<br />susceptibility information are available, they should be considered in selecting or modifying<br />antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns<br />may contribute to the empiric selection of therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefprozil are administered orally.<br />Population/Infection Dosage<br />(mg)<br />Duration<br />(days)<br />ADULTS (13 years and older)<br />UPPER RESPIRATORY TRACT<br />Pharyngitis/Tonsillitis<br />Acute Sinusitis<br />(For moderate to severe infections, the higher dose<br />should be used)<br />LOWER RESPIRATORY TRACT<br />Secondary Bacterial Infection of Acute Bronchitis and<br />Acute Bacterial Exacerbation of Chronic Bronchitis<br />SKIN AND SKIN STRUCTURE<br />Uncomplicated Skin and Skin Structure Infections<br />500 q24h 10a<br />250 q12h or<br />500 q12h<br />500 q12h<br />250 q12h or<br />500 q24h or<br />500 q12h<br />10a<br />10<br />10<br />10</p><p>CHILDREN (2 years-12 years)<br />UPPER RESPIRATORY TRACTb<br />Pharyngitis/Tonsillitis<br />SKIN AND SKIN STRUCTUREb<br />Uncomplicated Skin and Skin Structure Infections<br />7.5mg/kg q12h<br />20 mg/kg q24h<br />10a<br />10<br />INFANTS &amp; CHILDREN (6 months-12 years)<br />UPPER RESPIRATORY TRACTb<br />Otitis Media<br />Acute Sinusitis<br />(For moderate to severe infections, the higher dose<br />should be used)<br />15 mg/kg q12h<br />7.5 mg/kg q12h<br />or 15 mg/kg q12h<br />10<br />10</p><p>aIn the treatment of infections due to Streptococcus pyogenes, cefprozil should be<br />administered for at least 10 days.<br />bNot to exceed recommended adult doses.<br />Renal Impairment:<br />Cefprozil may be administered to patients with impaired renal function. The following dosage<br />schedule should be used.<br />Creatinine Clearance (mL/min) Dosage<br />(mg)<br />Dosing Interval<br />30-120 standard standard<br />0-29* 50% of standard standard</p><p>*Cefprozil is in part removed by hemodialysis; therefore, cefprozil should be administered after<br />the completion of hemodialysis.<br />Hepatic Impairment:<br />No dosage adjustment is necessary for patients with impaired hepatic function.<br />Directions for preparation:<br />1. Remove cap from bottle by pressing down and unscrewing.<br />2. Remove the desiccant capsule which is placed on the top of the bottle and discard.<br />3. Add sufficient quantity of water up to the bottle mark.<br />4. Replace the cap and shake well after addition of water until a homogeneous suspension is<br />obtained, check the volume and if required add water up to the bottle mark and shake well.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Cefprozil is contraindicated in patients with known allergy to the cephalosporin class of
antibiotics.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Warnings<br />Before Therapy with Cefproz is instituted, careful inquiry should be made to determine whether<br />the patient has had pervious hypersensitivity reaction to Cefprozil, cephalosporins, penicillin or<br />other drug. If Cefproz will be given to Penicillin sensitive patient, caution should be exercised<br />because of cross sensitivity among Beta-lactam antibiotic has been clearly documented and<br />incidace of cross sensitivity reach up to 10%. If any allergic reaction arise should discontinue<br />Cefproz treatment. Acute hypersensitivity reaction may require treatment with epinephrine and<br />other emergency measure including oxygen ventilation, intravenous fluids, IV antihistaminics,<br />corticosteroids, pressor amines and airway management as clinically indicated.<br />Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all<br />antibacterial agents, including Cefprozil, and may range in severity from mild diarrhea to fatal<br />colitis. Treatment with antibacterial agents alters the normal flora of the colon leading to<br />overgrowth of C. difficile. C. difficile produces toxins A and B which contribute to the<br />development of CDAD.</p><p>Hypertoxin-producing strains of C. difficile cause increased morbidity and mortality, as these<br />infections can be refractory to antimicrobial therapy and may require colectomy. CDAD must<br />be considered in all patients who present with diarrhea following antibiotic use. Careful medical<br />history is necessary since CDAD has been reported to occur over two months after the<br />administration of antibacterial agents.<br />If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. difficile may<br />need to be discontinued. Appropriate fluid and electrolyte management, protein<br />supplementation, antibiotic treatment of C. difficile, and surgical evaluation should be instituted<br />as clinically indicated.<br />Precautions<br />General:<br />Prescribing cefprozil in the absence of proven or strongly suspected bacterial infection or a<br />prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the<br />development of drug resistant bacteria.<br />In patients with known or suspected renal impairment, careful clinical observation and<br />appropriate laboratory studies should be done prior to and during therapy. The total daily dose<br />of cefprozil should be reduced in these patients because high and/or prolonged plasma antibiotic<br />concentrations can occur in such individuals from usual doses. Cephalosporins, including<br />cefprozil, should be given with caution to patients receiving concurrent treatment with potent<br />diuretics since these agents are suspected of adversely affecting renal function.<br />Prolonged use of cefprozil may result in the overgrowth of nonsusceptible organisms. Careful<br />observation of the patient is essential. If superinfection occurs during therapy, appropriate<br />measures should be taken.<br />Cefprozil should be prescribed with caution in individuals with a history of gastrointestinal<br />disease particularly colitis.<br />Positive direct Coombs&rsquo; tests have been reported during treatment with cephalosporin<br />antibiotics.</p><p>Patients should be counseled that antibacterial drugs including cefprozil should only be used to<br />treat bacterial infections. They do not treat viral infections (e.g., the common cold). When<br />cefprozil are prescribed to treat a bacterial infection, patients should be told that although it is<br />common to feel better early in the course of therapy, the medication should be taken exactly as<br />directed. Skipping doses or not completing the full course of therapy may (1) decrease the<br />effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will<br />develop resistance and will not be treatable by cefprozil or other antibacterial drugs in the<br />future.<br />Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is<br />discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery<br />and bloody stools (with or without stomach cramps and fever) even as late as two or more<br />months after having taken the last dose of the antibiotic. If this occurs, patients should contact<br />their physician as soon as possible.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nephrotoxicity has been reported following concomitant administration of aminoglycoside<br />antibiotics and cephalosporin antibiotics. Concomitant administration of probenecid doubled the<br />AUC for cefprozil.<br />The bioavailability of the capsule formulation of cefprozil was not affected when administered 5<br />minutes following an antacid.<br />Drug/Laboratory Test Interactions:<br />Cephalosporin antibiotics may produce a false positive reaction for glucose in the urine with<br />copper reduction tests (Benedict&rsquo;s or Fehling&rsquo;s solution or with Clinitest&reg; tablets), but not with<br />enzyme-based tests for glycosuria (e.g., Clinistix&reg;). A false negative reaction may occur in the<br />ferricyanide test for blood glucose. The presence of cefprozil in the blood does not interfere<br />with the assay of plasma or urine creatinine by the alkaline picrate method.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Teratogenic Effects- Pregnancy Category B:<br />Reproduction studies have been performed in rabbits, mice, and rats using oral doses of<br />cefprozil of 0.8, 8.5, and 18.5 times the maximum daily human dose (1000 mg) based upon<br />mg/m2, and have revealed no harm to the fetus. There are, however, no adequate and wellcontrolled<br />studies in pregnant women. Because animal reproduction studies are not always<br />predictive of human response, this drug should be used during pregnancy only if clearly needed.<br />Labor and Delivery:<br />Cefprozil has not been studied for use during labor and delivery. Treatment should only be<br />given if clearly needed.<br />Nursing Mothers:<br />Small amounts of cefprozil (&lt;0.3% of dose) have been detected in human milk following<br />administration of a single 1 gram dose to lactating women. The average levels over 24 hours<br />ranged from 0.25 to 3.3 mcg/mL. Caution should be exercised when cefprozil<br />are administered to a nursing woman, since the effect of cefprozil on nursing infants is<br />unknown.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefprozil are not known to affect your ability to drive and use machines. Make sure you know<br />how you react to your medicine before you drive, use machines, or engage in any other activity<br />that could be dangerous if you are not alert.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The adverse reactions to cefprozil are similar to those observed with other orally administered<br />cephalosporins. Cefprozil was usually well tolerated in controlled clinical trials. Approximately<br />2% of patients discontinued cefprozil therapy due to adverse events.<br />The most common adverse effects observed in patients treated with cefprozil are:<br />Gastrointestinal:<br />Diarrhea (2.9%), nausea (3.5%), vomiting (1%), and abdominal pain (1%).</p><p>Hepatobiliary:<br />Elevations of AST (SGOT) (2%), ALT (SGPT) (2%), alkaline phosphatase (0.2%), and<br />bilirubin values (&lt;0.1%). As with some penicillins and some other cephalosporin antibiotics,<br />cholestatic jaundice has been reported rarely.<br />Hypersensitivity:<br />Rash (0.9%), urticaria (0.1%). Such reactions have been reported more frequently in children<br />than in adults. Signs and symptoms usually occur a few days after initiation of therapy and<br />subside within a few days after cessation of therapy.<br />CNS:<br />Dizziness (1%). Hyperactivity, headache, nervousness, insomnia, confusion, and somnolence<br />have been reported rarely (&lt;1%). All were reversible.<br />Hematopoietic:<br />Decreased leukocyte count (0.2%), eosinophilia (2.3%).<br />Renal:<br />Elevated BUN (0.1%), serum creatinine (0.1%).<br />Other:<br />Diaper rash and superinfection (1.5%), genital pruritus and vaginitis (1.6%).<br />The following adverse events, regardless of established causal relationship to cefprozil, have<br />been rarely reported during postmarketing surveillance: anaphylaxis, angioedema, colitis<br />(including pseudomembranous colitis), erythema multiforme, fever, serum-sickness like<br />reactions,Stevens-Johnson syndrome, and thrombocytopenia.<br />Cephalosporin Class Paragraph:<br />In addition to the adverse reactions listed above which have been observed in patients treated<br />with cefprozil, the following adverse reactions and altered laboratory tests have been reported<br />for cephalosporin-class antibiotics:</p><p>Aplastic anemia, hemolytic anemia, hemorrhage, renal dysfunction, toxic epidermal necrolysis,<br />toxic nephropathy, prolonged prothrombin time, positive Coombs&rsquo; test, elevated LDH,<br />pancytopenia, neutropenia, agranulocytosis.<br />Several cephalosporins have been implicated in triggering seizures, particularly in patients with<br />renal impairment, when the dosage was not reduced. If seizures associated with drug therapy<br />occur, the drug should be discontinued. Anticonvulsant therapy can be given if clinically<br />indicated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Single 5000 mg/kg oral doses of cefprozil caused no mortality or signs of toxicity in adult,<br />weanling, or neonatal rats, or adult mice. A single oral dose of 3000 mg/kg caused diarrhea and<br />loss of appetite in cynomolgus monkeys, but no mortality.<br />Cefprozil is eliminated primarily by the kidneys. In case of severe overdosage, especially in<br />patients with compromised renal function, hemodialysis will aid in the removal of cefprozil<br />from the body.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefprozil is a semisynthetic, broad-spectrum cephalosporin antibiotic (which acts to inhibit cell<br />wall synthesis in suitable organisms); it is currently available in an oral dosage form (i.e., tablet<br />and suspension) for the treatment of respiratory-tract and skin or skin structure infections in<br />both adults and children. While this agent has provided acceptable clinical success rates for its<br />approved indications when the infecting pathogen is Streptococcus pneumoniae, the<br />pharmacodynamic profile of cefprozil against this important pathogen has not been fully<br />described. Therefore, the present study was undertaken to better define the in vivo activity of<br />cefprozil against S. pneumoniae using a neutropenic murine thigh infection model, those<br />isolates of S. pneumoniae were utilized in the neutropenic murine thigh infection model. Mice<br />were infected with 106 to 107 CFU per thigh, and therapy was initiated 2 h later. At 0 and 24 h<br />post infection, thighs were harvested to determine bacterial density. Survival was assessed</p><p>during 96 h of therapy. The magnitude of bacterial kill ranged from 0.5 to 4.4 log10 CFU per<br />thigh over 24 h, and the extent of microbial eradication was dependent on the MIC. Killing of<br />more than 2.6 log10 CFU per thigh was observed with MICs of &le;3 &mu;g/ml, while either minimal<br />killing or growth was detected with MICs of &ge;4 &mu;g/ml. Mortality in untreated control animals<br />was 100%. Animals infected with strains for which the MICs were &le;2 &mu;g/ml survived the<br />infection, whereas MICs exceeding 2 &mu;g/ml resulted in substantial mortality. These studies<br />demonstrate the effectiveness of cefprozil against isolates of the pneumococcus for which the<br />MICs are &le;2 &mu;g/ml using a drug exposure typically observed in children. These data support a<br />susceptibility breakpoint of &le;2 &mu;g/ml for cefprozil.<br />Microbiology<br />Cefprozil has in vitro activity against a broad range of gram-positive and gram-negative<br />bacteria. The bactericidal action of cefprozil results from inhibition of cell-wall synthesis.<br />Cefprozil has been shown to be active against most strains of the following microorganisms<br />both in vitro and in clinical infections</p><p>Aerobic gram-positive microorganisms: Aerobic gram-negative microorganisms:<br />Staphylococcus aureus (including &beta;-<br />lactamase-producing strains)<br />NOTE: Cefprozil is inactive against<br />methicillin-resistant staphylococci.<br />Haemophilus influenzae (including &beta;-lactamaseproducing<br />strains)<br />Moraxella (Branhamella) catarrhalis (including&beta;-<br />lactamase-Streptococcus pneumoniae producing strains)<br />Streptococcus pyogenes</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefprozil is an orally active cephalosporin which has demonstrated activity against a wide range<br />of organisms in vitro; it is relatively stable to hydrolysis by a number of beta-lactamases.</p><p>Following oral administration of cefprozil to fasting subjects, approximately 95% of the dose<br />was absorbed. The average plasma half-life in normal subjects was 1.3 hours, while the steadystate<br />volume of distribution was estimated to be 0.23 L/kg. The total body clearance and renal<br />clearance rates were approximately 3 mL/min/kg and 2.3 mL/min/kg, respectively. Average<br />peak plasma concentrations after administration of 250 mg, 500 mg, or 1 g doses of cefprozil to<br />fasting subjects were approximately 6.1, 10.5, and 18.3 &mu;g/mL, respectively.<br />During the first 4-hour period after drug administration, the average urine concentrations<br />following 250 mg, 500 mg, and 1 g doses were approximately700 &mu;g/mL, 1000 &mu;g/mL, and<br />2900 &mu;g/mL, respectively.<br />Administration of Cefprozil as tablet or suspension formulation with food did not affect the<br />extent of absorption (AUC) or the peak plasma concentration (Cmax) of cefprozil. However,<br />there was an increase of 0.25 to 0.75 hours in the time to maximum plasma concentration of<br />cefprozil (Tmax).<br />Plasma protein binding is approximately 36% and is independent of concentration in the range<br />of 2 &mu;g/mL to 20 &mu;g/mL.<br />There was no evidence of accumulation of cefprozil in the plasma in individuals with normal<br />renal function following multiple oral doses of up to 1000 mg every 8 hours for 10 days.<br />In patients with reduced renal function, the plasma half-life may be prolonged up to 5.2 hours<br />depending on the degree of the renal dysfunction. In patients with complete absence of renal<br />function, the plasma half-life of cefprozil has been shown to be as long as 5.9 hours. The halflife<br />is shortened during hemodialysis. Excretion pathways in patients with markedly impaired<br />renal function have not been determined. In patients with impaired hepatic function, the half-life<br />increases to approximately 2 hours. The magnitude of the changes does not warrant a dosage<br />adjustment for patients with impaired hepatic function.<br />Healthy geriatric volunteers (&ge;65 years old) who received a single 1-g dose of cefprozil had<br />35% to 60% higher AUC and 40% lower renal clearance values compared with healthy adult<br />volunteers 20 to 40 years of age. The average AUC in young and elderly female subjects was&nbsp;approximately 15% to 20% higher than in young and elderly male subjects. The magnitude of<br />these age- and gender-related changes in the pharmacokinetics of cefprozil is not sufficient to<br />necessitate dosage adjustments.<br />Adequate data on CSF levels of cefprozil are not available.<br />Comparable pharmacokinetic parameters of cefprozil are observed between pediatric patients (6<br />months to 12 years) and adults following oral administration of selected matched doses. The<br />maximum concentrations are achieved at 1 to 2 hours after dosing. The plasma elimination halflife<br />is approximately 1.5 hours. In general, the observed plasma concentrations of cefprozil in<br />pediatric patients at the 7.5, 15, and 30 mg/kg doses are similar to those observed within the<br />same time frame in normal adult subjects at the 250, 500, and 1000 mg doses, respectively.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No additional data of relevance.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose<br />Methyl cellulose<br />Croscarmellose sodium<br />Colloidal silicon dioxide<br />Sodium starch glycolate<br />Magnesium stearate<br />Instacoat flavour Yellow (Hydroxypropylmethylcellulose, Polyethylene glycol, Titanium<br />dioxide, Yellow iron oxide, Banana flavour),<br />Isopropyl alcohol and<br />Purified water<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>6.2 Incompatibilities<br />None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 Months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not Store above 30&deg;C prior reconstitution, Once reconstituted store in refrigerator between<br />2&deg;C to 8&deg;C and use within 14 days.<br />Keep out of reach of children.<br />Do not use after the expiry date stated on the label.<br />Do not use if there is any physical change on the product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Cefproz Suspension 250mg/5ml: Dry powder is light pink powder with pleasant tutti fruity<br />odour; Powder for 50ml of Suspension is filled in Type III amber glass bottle with silica gel on<br />the top of the bottle, sealed with white childproof cap, placed inside a box along with plastic<br />dosing spoon and a leaflet.<br />Reconstituted suspension is pink coloured moderately viscous, homogeneous suspension free<br />from foreign particles with sweet, pleasant fruity taste.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist<br />how to dispose of medicines no longer required. These measures will help to protect the<br />environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Medpharma Pharmaceutical & Chemical Industries L.L.C (Member of Valeant)
Industrial Area No. 13
Sharjah
United Arab Emirates
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                January 2020.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>